戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 20 min before and 150 min after the start of pentagastrin.
2 retion stimulated by intravenous infusion of pentagastrin.
3 delivery blocked the facilitatory effects of pentagastrin.
4 taglandin-independent effects of intravenous pentagastrin.
5 received an intravenous bolus of placebo and pentagastrin.
6 er in basal HPA axis activity or response to pentagastrin.
7        Microinjections of the CCK-B agonist, pentagastrin, (0.5 and 1.0 nmol/0.25 microliter) facilit
8 13 (17 nmol/0.25 microliter) 55 min prior to pentagastrin (1.0 nmol/0.25 microliter) delivery blocked
9                                              Pentagastrin administration induced acid secretion, but
10 t (BAO) and maximal acid output (MAO) during pentagastrin and insulin-induced hypoglycemia were measu
11 on of the cholecystokinin-B receptor agonist pentagastrin and placebo were evaluated in patients with
12 l motor nucleus reduced the acid response to pentagastrin by 29%.
13 ed dose-dependently the net acid response to pentagastrin by 40.8+/-11.1, 75.4+/-12.8 and 96.7+/-19.4
14 c.) 60 min after the start of an intravenous pentagastrin infusion; gastric acid secretion was monito
15  not ASPTV, decreased MAO (p < 0.05); (after pentagastrin, OPGV from 26.4 +/- 1.7 mEq/hour to 11.3 +/
16 sies, and measurement of peak acid output to pentagastrin (PAO(PG)).
17 act (TE) and synthetic human gastrin-17 I or pentagastrin (PG) were studied.
18                                              Pentagastrin (PG; 10 microg/kg IV) or saline was then gi
19         This surface acidity was enhanced by pentagastrin (pH 3.5 +/- 0.2) and eliminated by omeprazo
20 (P = .02) and ACTH (P = .01) levels, despite pentagastrin's robust stimulation of both hormones (P<.0
21 ally active as judged by their inhibition of pentagastrin stimulated acid secretion in conscious dogs
22  2.9 and ranged from 1.1 - 8.4 with a median pentagastrin stimulated gastric pH of 1.60 (range 1.0 -
23                  Immediately after basal and pentagastrin-stimulated acid and pepsin outputs were mea
24 lasma pharmacokinetics and the inhibition of pentagastrin-stimulated acid output following bolus intr
25 nist in vitro as judged by its inhibition of pentagastrin-stimulated acid secretion in an isolated, l
26 ability and is a potent inhibitor in vivo of pentagastrin-stimulated acid secretion in the rat when d
27 in 14 or the sst2 agonist DC 32-87 inhibited pentagastrin-stimulated acid secretion in wild-type mice
28 , there was a 79.0+/-3.9% peak inhibition of pentagastrin-stimulated acid secretion.
29 nd in the gastric mucosa, inhibits basal and pentagastrin-stimulated acid secretion.
30 te that bombesin acts in the VLRF to inhibit pentagastrin-stimulated gastric acid secretion through s
31 strin and somatostatin immunoreactivity, and pentagastrin-stimulated gastric acid secretion, were sim
32 to exhibit greater subjective sensitivity to pentagastrin than do normal subjects.
33   Patients' exaggerated anxiety responses to pentagastrin were normalized by the intervention.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。